0000880771-17-000124.txt : 20170816 0000880771-17-000124.hdr.sgml : 20170816 20170816175512 ACCESSION NUMBER: 0000880771-17-000124 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170815 FILED AS OF DATE: 20170816 DATE AS OF CHANGE: 20170816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cheung Wilson Wai-Shun CENTRAL INDEX KEY: 0001291656 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19825 FILM NUMBER: 171037241 MAIL ADDRESS: STREET 1: SCICLONE PHARMACEUTICALS, INC. STREET 2: 950 TOWER LANE, SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000880771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943116852 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 BUSINESS PHONE: 650-358-3456 MAIL ADDRESS: STREET 1: 950 TOWER LANE STREET 2: SUITE 900 CITY: FOSTER CITY STATE: CA ZIP: 94404-2125 4 1 certent-form4.xml PRIMARY DOCUMENT X0306 4 2017-08-15 0000880771 SCICLONE PHARMACEUTICALS INC SCLN 0001291656 Cheung Wilson Wai-Shun 950 TOWER LANE, SUITE 900 FOSTER CITY CA 94404 0 1 0 0 CFO & Senior VP, Finance Common Stock 2017-08-15 4 M 0 30000 0 A 31872 D Common Stock 2017-08-15 4 F 0 14714 11.05 D 17158 D Restricted Stock Unit 2017-08-15 4 M 0 30000 0 D Common Stock 30000 127000 D Shares disposed represent shares withheld to cover withholding tax obligations in connection with the vesting of Restricted Stock Units. Granted under the Issuer's 2015 Equity Incentive Plan. Each restricted stock unit represents the right to receive, at settlement, one share of common stock. Each RSU will vest and be settled on August 15, 2017, subject to the reporting person's continued employment, but will terminate upon the occurrence of a change in control on or before March 31, 2017. /s/ Wilson W. Cheung 2017-08-16